Sara’s journey to managing relapsing multiple sclerosis (MS) started with her diagnosis back in 2005. She had just graduated from college and was beginning her career in healthcare administration. Driving home one day, Sara experienced blurry vision in her right eye. Following a series of doctor visits and tests, Sara was surprised to find out that she had MS. She and her family were shocked and scared—and wondered what the future would hold for her.
Sara began treatment for her relapsing MS with an injectable medication, which she found daunting. Her treatment involved injecting herself multiple times per week—a course Sara followed for three years. During that time, Sara had gotten married and wanted to have children, so she and her neurologist agreed to discontinue the injectable treatment.
Following the birth of her second child, Sara began noticing what she thought could be a return of her MS symptoms. Her family urged her to go back to her neurologist to get a clearer picture of what was going on with her health. An MRI showed that new lesions had appeared, confirming that Sara’s relapsing MS was responsible for her symptoms. Sara and her neurologist discussed available treatment options, and together they decided that Sara would begin treatment with ZEPOSIA, a once-daily pill, as a participant in ZEPOSIA clinical studies.
ZEPOSIA® (ozanimod) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is not known if ZEPOSIA is safe and effective in children.
Sara believes the decision to treat her relapsing MS with ZEPOSIA was a good one: “I’m very glad that my doctor and I chose to start ZEPOSIA to treat my relapsing MS. It’s a pill. It doesn’t require refrigeration. You take it once a day at the same time, with or without food.”
Today, Sara enjoys staying busy with her favorite activities: she exercises, stays close with her family, and spends a lot of time at the soccer field with her sons. She’s really looking forward to watching her sons continue to learn and grow.
Sara is excited about the future. She’s learned quite a bit about living with relapsing MS since her diagnosis in 2005—including what works best for her: “I think it’s important for people with relapsing MS to understand that it’s not the end of the road. Partner with your healthcare team to make sure you’re on the treatment that’s right for you.”
Visit ZEPOSIA.com to see clinical results with ZEPOSIA.
Your MS healthcare team can tell you even more about ZEPOSIA. Schedule an appointment to ask about ZEPOSIA and whether it may be right for you.
You can also learn more by speaking with a ZEPOSIA 360 Support™ Nurse Navigator at 1-833-ZEPOSIA (833-937-6742), Monday to Friday, 8 AM – 8 PM ET.
Do not take ZEPOSIA if you:
Talk to your healthcare provider before taking ZEPOSIA if you have any of these conditions or do not know if you have any of these conditions.
ZEPOSIA may cause serious side effects, including:
Your healthcare provider may delay starting or may stop your ZEPOSIA treatment if you have an infection.
Follow directions from your healthcare provider when starting ZEPOSIA and when you miss a dose.
Continue reading for additional possible serious side effects of ZEPOSIA.
Before taking ZEPOSIA, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take or have recently taken, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using ZEPOSIA with other medicines can cause serious side effects. Especially tell your healthcare provider if you take or have taken:
You should not receive live vaccines during treatment with ZEPOSIA, for at least 1 month before taking ZEPOSIA and for 3 months after you stop taking ZEPOSIA. Vaccines may not work as well when given during treatment with ZEPOSIA.
ZEPOSIA can cause serious side effects, including:
The most common side effects of ZEPOSIA can include:
These are not all of the possible side effects of ZEPOSIA. For more information, ask your healthcare provider or pharmacist.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see full Prescribing Information, including Medication Guide.
ZEPOSIA® is a registered trademark and ZEPOSIA 360 Support™ is a trademark of Celgene Corporation, a Bristol-Myers Squibb Company.
© 2020 Bristol-Myers Squibb Company. All rights reserved. 11/20 US-ZEP-20-0737
Get regular updates to your inbox.